A phase III randomized double-blind pivotal trial of immunotherapy with a polyvalent melanoma vaccine, CancerVax vaccine [cancer vaccine] plus BCG versus placebo plus BCG as a post-surgical treatment for stage IV melanoma

Trial Profile

A phase III randomized double-blind pivotal trial of immunotherapy with a polyvalent melanoma vaccine, CancerVax vaccine [cancer vaccine] plus BCG versus placebo plus BCG as a post-surgical treatment for stage IV melanoma

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2005

At a glance

  • Drugs BCG; Cancer vaccine
  • Indications Malignant melanoma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 03 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top